Nelson Kimberly A 4

What Happened Kimberly A. Nelson, a director of Colgate-Palmolive Co. (CL), received two types of equity awards on May 11, 2026 as part of the company's annual director compensation. She was credited with 2,075 stock units (acquired at $0.00) and granted 2,424 option-style/derivative awards (also recorded at $0.00). These were grants/awards (code A), not open-market purchases or sales, and required no cash payment by the insider.

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (appears timely — within the usual two-business-day filing period).
• Award amounts: 2,075 stock units @ $0.00; 2,424 derivative/option awards @ $0.00.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — stock units credited to a stock unit account under the issuer’s incentive compensation plan. F2 — annual director stock option grant under the plan. F3 — the option awards vest/become exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant.
• Transaction type: Compensation grant (routine director award), not a purchase or sale.

Context These are routine, non-cash director compensation awards and do not reflect an open-market buy or sell. The derivative component is an option-style award with multi-year vesting (so any future market exposure will depend on vesting and any subsequent exercise or sale). As with most director grants, the filing documents the award but does not indicate the insider’s intent to buy or sell shares.